Equities analysts predict that Procter & Gamble Co (NYSE:PG) will post sales of $17.20 billion for the current quarter, according to Zacks Investment Research. Eight analysts have issued estimates for Procter & Gamble’s earnings, with the highest sales estimate coming in at $17.49 billion and the lowest estimate coming in at $17.01 billion. Procter & Gamble reported sales of $17.40 billion during the same quarter last year, which indicates a negative year-over-year growth rate of 1.1%. The business is scheduled to issue its next quarterly earnings results on Tuesday, January 22nd.

On average, analysts expect that Procter & Gamble will report full year sales of $66.88 billion for the current financial year, with estimates ranging from $66.47 billion to $67.84 billion. For the next fiscal year, analysts anticipate that the company will report sales of $69.01 billion, with estimates ranging from $68.04 billion to $69.91 billion. Zacks’ sales averages are a mean average based on a survey of research firms that follow Procter & Gamble.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Friday, October 19th. The company reported $1.12 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.09 by $0.03. The business had revenue of $16.69 billion for the quarter, compared to analysts’ expectations of $16.45 billion. Procter & Gamble had a return on equity of 21.20% and a net margin of 15.10%. The company’s revenue for the quarter was up .2% on a year-over-year basis. During the same period in the prior year, the firm earned $1.09 EPS.

Several analysts recently weighed in on PG shares. Jefferies Financial Group restated a “hold” rating and set a $86.00 price target on shares of Procter & Gamble in a report on Friday, November 9th. TD Securities restated a “hold” rating on shares of Procter & Gamble in a report on Thursday, November 8th. Bank of America increased their price target on Procter & Gamble from $92.00 to $95.00 and gave the company a “neutral” rating in a report on Tuesday, November 6th. ValuEngine upgraded Procter & Gamble from a “hold” rating to a “buy” rating in a report on Wednesday, October 24th. Finally, Zacks Investment Research upgraded Procter & Gamble from a “sell” rating to a “hold” rating in a report on Wednesday, October 24th. One analyst has rated the stock with a sell rating, fourteen have given a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $88.38.

In other Procter & Gamble news, CEO David S. Taylor sold 63,113 shares of the company’s stock in a transaction on Friday, November 9th. The stock was sold at an average price of $91.68, for a total value of $5,786,199.84. Following the transaction, the chief executive officer now owns 226,393 shares of the company’s stock, valued at approximately $20,755,710.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Ioannis Skoufalos sold 6,000 shares of the company’s stock in a transaction on Friday, August 24th. The shares were sold at an average price of $83.17, for a total value of $499,020.00. Following the completion of the transaction, the insider now directly owns 14,543 shares in the company, valued at approximately $1,209,541.31. The disclosure for this sale can be found here. Insiders sold a total of 509,031 shares of company stock worth $46,738,909 in the last ninety days. 1.84% of the stock is currently owned by corporate insiders.

Institutional investors have recently made changes to their positions in the business. HC Financial Advisors Inc. bought a new position in shares of Procter & Gamble during the 4th quarter worth $1,738,000. Buckley Wealth Management LLC grew its position in shares of Procter & Gamble by 72.0% during the 1st quarter. Buckley Wealth Management LLC now owns 35,090 shares of the company’s stock worth $2,782,000 after buying an additional 14,688 shares in the last quarter. Connecticut Wealth Management LLC boosted its position in Procter & Gamble by 14.5% during the first quarter. Connecticut Wealth Management LLC now owns 9,245 shares of the company’s stock valued at $716,000 after purchasing an additional 1,168 shares in the last quarter. Penserra Capital Management LLC boosted its position in Procter & Gamble by 39.3% during the first quarter. Penserra Capital Management LLC now owns 5,435 shares of the company’s stock valued at $430,000 after purchasing an additional 1,532 shares in the last quarter. Finally, Parallel Advisors LLC boosted its position in Procter & Gamble by 56.4% during the first quarter. Parallel Advisors LLC now owns 43,191 shares of the company’s stock valued at $3,424,000 after purchasing an additional 15,574 shares in the last quarter. 58.57% of the stock is currently owned by institutional investors.

Shares of PG traded down $0.25 during mid-day trading on Friday, hitting $91.85. 735,438 shares of the stock were exchanged, compared to its average volume of 12,657,392. The stock has a market capitalization of $235.18 billion, a price-to-earnings ratio of 21.79, a price-to-earnings-growth ratio of 3.06 and a beta of 0.37. Procter & Gamble has a 52-week low of $70.73 and a 52-week high of $94.81. The company has a debt-to-equity ratio of 0.40, a current ratio of 0.80 and a quick ratio of 0.62.

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, November 15th. Shareholders of record on Friday, October 19th were given a $0.7172 dividend. This represents a $2.87 annualized dividend and a yield of 3.12%. The ex-dividend date was Thursday, October 18th. Procter & Gamble’s dividend payout ratio (DPR) is presently 68.01%.

About Procter & Gamble

The Procter & Gamble Company provides branded consumer packaged goods to consumers in North America, Europe, the Asia Pacific, Greater China, Latin America, India, the Middle East, and Africa. The company operates in five segments: Beauty; Grooming; health Care; fabric & Home Care; and Baby, Feminine & Family Care.

Recommended Story: Do You Need a Fiduciary?

Get a free copy of the Zacks research report on Procter & Gamble (PG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.